Detalhe da pesquisa
1.
Trends in overall mortality among US veterans with primary myelofibrosis.
BMC Cancer
; 23(1): 48, 2023 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641455
2.
Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis.
Blood
; 135(19): 1696-1703, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32107559
3.
Ruxolitinib Re-Treatment in Patients with Myelofibrosis: Real-World Evidence on Patient Characteristics and Outcomes.
Acta Haematol
; 145(4): 448-453, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008087
4.
Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
BMC Cancer
; 21(1): 691, 2021 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112113
5.
Patient Perspectives Regarding Allogeneic Bone Marrow Transplantation in Myelofibrosis.
Biol Blood Marrow Transplant
; 25(2): 398-402, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30292010
6.
Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis.
Biol Blood Marrow Transplant
; 25(11): 2267-2273, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31288096
7.
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
Blood
; 130(17): 1889-1897, 2017 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074595
8.
Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data.
Ann Hematol
; 98(11): 2533-2539, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31552445
9.
Development of a symptom assessment in patients with myelofibrosis: qualitative study findings.
Health Qual Life Outcomes
; 17(1): 61, 2019 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30975150
10.
How we diagnose and treat systemic mastocytosis in adults.
Br J Haematol
; 180(1): 11-23, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29048112
11.
Cytoreductive treatment patterns among US veterans with polycythemia vera.
BMC Cancer
; 18(1): 528, 2018 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29728092
12.
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms.
Hematol Oncol
; 36(5): 740-748, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30074634
13.
Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)-I study.
Br J Haematol
; 198(6): 1065-1068, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751150
14.
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.
Blood
; 125(17): 2649-55, 2015 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25762180
15.
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Haematologica
; 102(1): 85-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540137
16.
Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.
Cancer
; 122(3): 477-85, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26670597
17.
The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
Cancer
; 122(12): 1888-96, 2016 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27070130
18.
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients.
Blood
; 123(24): 3803-10, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24553173
19.
Myeloproliferative neoplasm patient symptom burden and quality of life: evidence of significant impairment compared to controls.
Am J Hematol
; 90(10): 864-70, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26113113
20.
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development.
Mediators Inflamm
; 2015: 284706, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538823